Ticker
NTLACompany Name
INTELLIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 898.89M | $ 156.17M | 17.37% |
3/31/2025 | $ 986.16M | $ 126.88M | 12.87% |
12/31/2024 | $ 1.19B | $ 189.18M | 15.88% |
9/30/2024 | $ 1.17B | $ 120.5M | 10.27% |
6/30/2024 | $ 1.19B | $ 130.85M | 10.98% |
3/31/2024 | $ 1.26B | $ 171.98M | 13.65% |
12/31/2023 | $ 1.3B | $ 226.75M | 17.43% |
9/30/2023 | $ 1.24B | $ 168.03M | 13.51% |
6/30/2023 | $ 1.32B | $ 171.81M | 12.98% |
3/31/2023 | $ 1.42B | $ 294.15M | 20.75% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for INTELLIA THERAPEUTICS INC is calculated as follows: CashnEq [ $ 179.75M ] / Assets [ $ 458.56M ]
(=) Cash to Assets [ 39.2% ]
Minimum
Dec 31, 2021
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.44% |
std | 9.6% |